Global income investors have spent most of this cycle picking between two extremes: broad, low-cost international dividend funds that dilute yield across hundreds of names, or concentrated high-yield strategies that lean heavily on European banks and telecoms. The Xtrackers MSCI EAFE High Dividend Yield Equity ETF (NYSEARCA:HDEF) sits between those poles, and its portfolio construction is what makes it worth a look right now alongside the iShares International Select Dividend ETF (NYSEARCA:IDV) and the Vanguard International High Dividend Yield ETF (NASDAQ:VYMI).
With the 10-year Treasury yielding almost 4.5% and sitting in the 95th percentile of its trailing twelve-month range, the bar for equity income has risen. A fund needs to justify its risk with real yield, real diversification, or both. These three ETFs answer that challenge in meaningfully different ways.
Why EAFE Income Looks Different in 2026
Developed international dividends have been the quiet story of the year. Franklin Templeton’s 2026 outlook argues that broadening opportunities across global capital markets, driven by attractive profits growth outside the United States and by global monetary policy easing, favor non-US equities. Morningstar echoes the point on the UK specifically, noting that UK stocks trade at a deep discount to US equities, with dividend yields among the highest in the G7.
That backdrop matters because EAFE dividend funds are effectively concentrated bets on UK, Swiss, Japanese, and European multinationals with long payout histories. The question is which packaging fits which investor.
HDEF: A Quality Screen Sitting on Top of Yield
The iShares International Developed Markets Dividend ETF tracks the MSCI EAFE High Dividend Yield Index, which applies a quality and dividend-sustainability screen to a straight yield ranking. That is the mechanism worth focusing on. Stocks must pass tests for balance-sheet strength and payout consistency before ranking by yield, which is designed to filter out the classic value-trap names that dominate naive high-yield screens.
The current portfolio reflects that filter. Top positions include Roche at 5.86% and Novartis at 5.78%, followed by Nestlé at 4.77% and Shell at 4.76%. Swiss pharma alone accounts for a large share of the fund, with Roche, Novartis, and Sanofi combined accounting for 13.2% of net assets. Energy is the other pillar, with Shell, TotalEnergies, Iberdrola, Equinor, Repsol, Woodside, and Santos representing roughly 18.5% of the portfolio.
Distributions are quarterly but lumpy, with a fat mid-year payment and smaller stubs the rest of the year. The June 2026 distribution came in at $0.7142 per share, up from $0.63065 in June 2025 and $0.55626 in June 2024. That is the pattern to plan around if you rely on the income schedule.
Performance has kept pace with the broader EAFE dividend trade. HDEF is up 8% year-to-date and 17% over the trailing year, with a five-year total return of 68%. Assets under management total roughly $2.4 billion, which is sufficient liquidity for most retail buyers but well below that of mega-cap peers. The tradeoff is concentration in Swiss and UK names, plus meaningful exposure to Big Tobacco through British American Tobacco at 3.27%. Investors who screen out tobacco or want less pharma weighting should look elsewhere.
IDV: The Higher-Yield, More Concentrated Cousin
The iShares International Select Dividend ETF takes a purer yield-first approach, tracking the Dow Jones EPAC Select Dividend Index with roughly 100 names screened primarily on payout history and yield. That produces a more concentrated portfolio that leans harder into financials, utilities, and materials than the iShares International Developed Markets Dividend ETF does. The mechanism is straightforward: less quality overlay, more raw dividend capture.
The income has shown up. IDV’s June 2026 distribution jumped to $1.101643 per share, well above $0.787115 in June 2025 and $0.728345 in June 2024. Investors should note that quarterly amounts swing widely, with Q1 and Q4 payments running a fraction of the mid-year checks.
Price performance has been the standout of the group. IDV has returned 10% year to date and 27% over the past year, aided by rallies in European banks and UK energy names. The expense ratio is 0.50%, the highest of the three, reflecting the older iShares product structure. The iShares International Select Dividend ETF suits investors who want maximum current yield from developed international markets and can tolerate heavier cyclical exposure. It is the fund most likely to disappoint in a European banking wobble, and the least diversified across sectors.
VYMI: The Cheapest, Broadest Alternative
The Vanguard International High Dividend Yield ETF is the odd fund out on this list because it is not EAFE-only. It includes emerging markets, which meaningfully changes the risk profile. What earns it a spot is the combination of scale, breadth, and a rock-bottom expense ratio of 0.07%. That is the cheapest way to get a diversified basket of above-average-yielding non-U.S. stocks, period.
The fund tracks the FTSE All-World ex-US High Dividend Yield Index, which spans well over 1,000 holdings across Europe, Asia, and emerging markets. Individual name risk is negligible. The trade-off is that emerging-market dividend payers behave differently from developed European staples, adding currency and political risk that HDEF and IDV largely avoid.
Returns reflect that broader mandate. VYMI is up 14% year-to-date and 29% over the past year, with a five-year gain of 86%. Both figures top HDEF and IDV, benefiting from a weaker dollar tailwind that Franklin Templeton and others expect to persist.
Which Fund Fits Which Investor
The choice comes down to what you actually want from a global income sleeve.
- Choose HDEF if you want EAFE-only exposure with a quality screen that avoids stretched payouts. It is the middle path: less yield than IDV, less breadth than VYMI, but the cleanest expression of a quality-plus-yield thesis in developed markets outside North America.
- Choose IDV if current yield is the priority and you accept concentration in European financials and energy. The higher expense ratio is real, but the payout mechanism delivers.
- Choose VYMI if you want the broadest, cheapest instrument and are comfortable adding emerging market exposure to your income sleeve. It is the default core holding for a global dividend allocation.
Investors building a diversified income book do not have to pick one. Pairing HDEF’s quality tilt with VYMI’s breadth is a defensible combination that limits overlap while spreading regional risk. IDV works better as a satellite than a core, especially at current European bank valuations.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks